GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 8,052.6 million compared to INR 8,023 million a year ago. Revenue was INR 8,333.7 million compared to INR 8,257.2 million a year ago. Net income was INR 457.2 million compared to INR 1,645.6 million a year ago. Basic earnings per share from continuing operations was INR 2.7 compared to INR 9.71 a year ago. Diluted earnings per share from continuing operations was INR 2.7 compared to INR 9.71 a year ago. Basic earnings per share was INR 2.7 compared to INR 9.71 a year ago. Diluted earnings per share was INR 2.7 compared to INR 9.71 a year ago.
For the nine months, sales was INR 25,239.1 million compared to INR 24,642.7 million a year ago. Revenue was INR 26,166.7 million compared to INR 25,372.7 million a year ago. Net income was INR 3,954.8 million compared to INR 4,772.6 million a year ago. Basic earnings per share from continuing operations was INR 23.35 compared to INR 27.99 a year ago. Diluted earnings per share from continuing operations was INR 23.35 compared to INR 27.99 a year ago. Basic earnings per share was INR 23.35 compared to INR 28.17 a year ago. Diluted earnings per share was INR 23.35 compared to INR 28.17 a year ago.